Kythera Biopharmaceuticals (KYTH) in Focus: Stock Surges 25.1% - Analyst Blog
September 18 2013 - 9:00AM
Zacks
Kythera Biopharmaceuticals,
Inc. (KYTH) was a big mover last session, as the company
saw its shares surge by more than 25% on the day. The move came on
solid volume too, as far more shares changed hands than in a normal
session. This continues the recent uptrend for the company, as the
stock has gained more than 78% in the past one-month time
frame.
The company has seen two negative
revisions and a single positive revision in the past two months.
Also, its earnings consensus has moved lower over the same time
frame, suggesting there may be trouble down the road. So make sure
to keep an eye on this stock going forward to see if this recent
rally can last.
KYTH currently has a Zacks Rank #3
(Hold) while its Earnings ESP is positive.
Some better performing
Med-BioMed/Gene stocks include Actelion Ltd.
(ALIOF), Affymetrix Inc. (AFFX) and Gilead
Sciences Inc. (GILD). All these stocks hold a Zacks Rank
#1 (Strong Buy).
Want the latest recommendations
from Zacks Investment Research? Today, you can download 7 Best
Stocks for the Next 30 Days. Click to get this free report
>>
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
ACTELION LTD (ALIOF): Get Free Report
GILEAD SCIENCES (GILD): Free Stock Analysis Report
KYTHERA BIOPHRM (KYTH): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024